Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which pacing mode works best for heart failure? new study investigates

NCT ID NCT03779802

Knowledge-focused Sponsor: CMC Ambroise Paré Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how different pacing modes affect blood pressure in people with heart failure who have a special pacemaker called a CRT device. Researchers measured the highest blood pressure achieved with each mode to see which one works best. The study included 50 adults who had recently received a CRT device, but it was stopped early.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Apr 2019

Finished

Apr 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient older than 18 * Implantation of a CRT (CRT-P or CRT-D) less than 3 months before inclusion * MPP and SyncAV-enabled ABBOTT Quadripolar CRT pacing system * Patient who had signed an informed consent and is willing to comply with study requirements * De novo implantation * Patient covered by national healthcare insurance Exclusion Criteria: * Permanent/persistant atrial fibrillation/ supra-ventricular tachycardia * Pacing indication for 2nd or 3rd degree AV block * Upgrading from non-CRT system * Pregnant or breastfeeding women * Adult under legal protection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac resynchronization therapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac resynchronization therapy Heart failure

Contacts and locations

Locations

  • CHU Poitiers

    Poitiers, France

  • Cmc Ambroise Pare

    Neuilly-sur-Seine, 92200, France

  • Gehm Site D'Eaubonne

    Eaubonne, Val-d'Oise, 95600, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.